Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

Residents of Badiyadka village in Kasaragod have raised Rs. 42 lakh for Prashanth Rai, a Hindi teacher battling blood cancer.

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...

Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...

The batteries will be recyclable, in keeping with the Embleme’s philosophy – half of the concept’s materials are recycled and the carbon footprint of its components reduced by 70 per cent. This is an ...

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second p ...

A Toowoomba resident came face-to-face with a redicivist criminal who has spent a majority of his adult life serving jail ...

Royal Bank of Canada reaffirmed their outperform rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...